Insmed Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
65.63
-2.65
(-3.88%)
Volume:
3,556,351
52 week range:
21.92 - 84.91
Market Cap:
11.954B
Company Description:
Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1.